Cold & Flu

Published 03/08/2017

Author: Nicholas Hall's reports

(411 pages)
Click here for a detailed breakdown of this report's contents.

This report is an in-depth exploration of the OTC Cold & Flu market, including Systemic cold & flu, Topical decongestants and Chest rubs & inhalants, plus VMS brands positioned for immunity, and includes coverage of 20 major markets from across the globe, with topline sales, brand performances, new developments, launches and A+P campaigns.

With full-year 2016 OTC sales from DB6 2017, it also includes case studies of key OTC Cold & Flu brands, highlighting success factors, sales, NPD and A+P activity, with forecasts sales for all categories and countries, plus predictions for the future.

DescriptionCountry LicenceGlobal LicenceBuy Country LicenceBuy Global Licence 
+ Full report £8,500.00 £10,000.00 Clear